Antifungal potential of multi-drug-resistant Pseudomonas aeruginosa: harnessing pyocyanin for candida growth inhibition
- PMID: 38846355
- PMCID: PMC11155300
- DOI: 10.3389/fcimb.2024.1375872
Antifungal potential of multi-drug-resistant Pseudomonas aeruginosa: harnessing pyocyanin for candida growth inhibition
Abstract
Introduction: Pseudomonas aeruginosa is notorious for its multidrug resistance and its involvement in hospital-acquired infections. In this study, 20 bacterial strains isolated from soil samples near the Hindan River in Ghaziabad, India, were investigated for their biochemical and morphological characteristics, with a focus on identifying strains with exceptional drug resistance and pyocyanin production.
Methods: The isolated bacterial strains were subjected to biochemical and morphological analyses to characterize their properties, with a particular emphasis on exopolysaccharide production. Strain GZB16/CEES1, exhibiting remarkable drug resistance and pyocyanin production. Biochemical and molecular analyses, including sequencing of its 16S rRNA gene (accession number LN735036.1), plasmid-curing assays, and estimation of plasmid size, were conducted to elucidate its drug resistance mechanisms and further pyocynin based target the Candida albicans Strain GZB16/CEES1 demonstrated 100% resistance to various antibiotics used in the investigation, with plasmid-curing assays, suggesting plasmid-based resistance gene transmission. The plasmid in GZB16/CEES1 was estimated to be approximately 24 kb in size. The study focused on P. aeruginosa's pyocyanin production, revealing its association with anticandidal activity. The minimum inhibitory concentration (MIC) of the bacterial extract against Candida albicans was 50 μg/ml, with a slightly lower pyocyanin-based MIC of 38.5 μg/ml. Scanning electron microscopy illustrated direct interactions between P. aeruginosa strains and Candida albicans cells, leading to the destruction of the latter.
Discussion: These findings underscore the potential of P. aeruginosa in understanding microbial interactions and developing strategies to combat fungal infections. The study highlights the importance of investigating bacterial-fungal interactions and the role of pyocyanin in antimicrobial activity. Further research in this area could lead to the development of novel therapeutic approaches for combating multidrug-resistant infections.
Keywords: Pseudomonas aeruginosa; anti-candida; antifungal; drug resistance; exopolysaccharide; plasmid; pyocyanin.
Copyright © 2024 Oves, Khan, Al-Shaeri and Khan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures









Similar articles
-
Pharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamargine.J Ethnopharmacol. 2021 Nov 15;280:114473. doi: 10.1016/j.jep.2021.114473. Epub 2021 Jul 31. J Ethnopharmacol. 2021. PMID: 34343650
-
Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.J Infect Chemother. 2013 Feb;19(1):82-8. doi: 10.1007/s10156-012-0457-9. Epub 2012 Aug 3. J Infect Chemother. 2013. PMID: 22865331
-
Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.J Clin Pathol. 1999 May;52(5):385-7. doi: 10.1136/jcp.52.5.385. J Clin Pathol. 1999. PMID: 10560362 Free PMC article.
-
Prospects of Synthetic Biology-Based Approaches in the Enhanced Production of Pyocyanin in Pseudomonas aeruginosa MCCB 117 as the Drug of Choice in Aquaculture.Curr Microbiol. 2025 Jun 3;82(7):322. doi: 10.1007/s00284-025-04279-x. Curr Microbiol. 2025. PMID: 40459729 Review.
-
Pseudomonas aeruginosa's greenish-blue pigment pyocyanin: its production and biological activities.Microb Cell Fact. 2023 Jun 8;22(1):110. doi: 10.1186/s12934-023-02122-1. Microb Cell Fact. 2023. PMID: 37291560 Free PMC article. Review.
References
-
- Abd El-Baky R. M., Mandour S. A., Ahmed E. F., Hashem Z. S., Sandle T., Mohamed D. S. (2020). Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections. PloS One 15, e0243418. doi: 10.1371/journal.pone.0243418 - DOI - PMC - PubMed
-
- Akram F., Imtiaz M., ul Haq I. (2022). Emergent crisis of antibiotic resistance: A silent pandemic threat to 21st century. Microbial. Pathogen. 174, 105923. - PubMed
-
- Araos R., D’Agata E. (2019). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 9th Edition. Chapter 219 Pseudomonas aeruginosa and Other a Pseudomonas Species, 2686-2699.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources